Bioorganic and Medicinal Chemistry p. 2518 - 2526 (2013)
Update date:2022-08-03
Topics:
Narumi, Tetsuo
Arai, Hiroshi
Yoshimura, Kazuhisa
Harada, Shigeyoshi
Hirota, Yuki
Ohashi, Nami
Hashimoto, Chie
Nomura, Wataru
Matsushita, Shuzo
Tamamura, Hirokazu
Several CD4 mimics have been reported as HIV-1 entry inhibitors that can intervene in the interaction between a viral envelope glycoprotein gp120 and a cell surface protein CD4. Our previous SAR studies led to a finding of a highly potent analogue 3 with bulky hydrophobic groups on a piperidine moiety. In the present study, the aromatic ring of 3 was modified systematically in an attempt to improve its antiviral activity and CD4 mimicry which induces the conformational changes in gp120 that can render the envelope more sensitive to neutralizing antibodies. Biological assays of the synthetic compounds revealed that the introduction of a fluorine group as a meta-substituent of the aromatic ring caused an increase of anti-HIV activity and an enhancement of a CD4 mimicry, and led to a novel compound 13a that showed twice as potent anti-HIV activity compared to 3 and a substantial increase in a CD4 mimicry even at lower concentrations.
View MoreHangzhou Share Chemical Co., Ltd
Contact:+86-57187093700
Address:Hang Xing Road
Dalian Synco Chemical Co., Ltd.
Contact:+86-411-83635150
Address:Rm 1004, 24, Tangshan Street, Dalian
Contact:86-21-50966856
Address:Building 5,300 Chuanzhan Road,Pudong New District,Shanghai
LianYunGang Chiral Chemical(CHINA) CO.,LTD
Contact:+86-518-83616958 +86-519-82884848
Address:LianYunGang Chemical Industry Park (JiangSu)
ShanDong XinDa Chemical CO.,LTD
Contact:086-0311-87580543
Address:No.168, High Technology Development Zone Jinan Shandong China
Doi:10.1016/j.tet.2004.01.092
(2004)Doi:10.1016/j.bmc.2003.12.036
(2004)Doi:10.1081/SCC-120018690
(2003)Doi:10.1016/j.jorganchem.2011.11.009
(2012)Doi:10.17179/excli2016-692
(2017)Doi:10.1002/1099-0690(200210)2002:19<3254::AID-EJOC3254>3.0.CO;2-6
(2002)